SmPC- Cisplatin 1mg/ml Concentrate for solution for infusion: Change history
View Summary of Product Characteristics (SmPC- Cisplatin 1mg/ml Concentrate for solution for infusion)
Last updated on this site: 12 Jan 2023
To update sections 4.3, 4.4, 4.5, 4.6, 4.8, 4.9 and 5.3 of the SmPC to bring in-line with reference product (Cisplatin 1 mg/ml Concentrate for Solution for Infusion & MAH: Pfizer Healthcare Ireland, Ireland) for Cisplatin 1 mg/ml Concentrate for Solution for Infusion. Consequentially, the PIL has also been updated.
View Summary of Product Characteristics (SmPC- Cisplatin 1mg/ml Concentrate for solution for infusion)
Last updated on this site: 12 Jan 2023
To update sections 4.3, 4.4, 4.5, 4.6, 4.8, 4.9 and 5.3 of the SmPC to bring in-line with reference product (Cisplatin 1 mg/ml Concentrate for Solution for Infusion & MAH: Pfizer Healthcare Ireland, Ireland) for Cisplatin 1 mg/ml Concentrate for Solution for Infusion. Consequentially, the PIL has also been updated.
-
Changes: (Updated: 12 Jan 2023)
To update sections 4.3, 4.4, 4.5, 4.6, 4.8, 4.9 and 5.3 of the SmPC to bring in-line with reference product (Cisplatin 1 mg/ml Concentrate for Solution for Infusion & MAH: Pfizer Healthcare Ireland, Ireland) for Cisplatin 1 mg/ml Concentrate for Solution for Infusion. Consequentially, the PIL has also been updated.
-
Changes: (Updated: 20 Sep 2022)
Initial upload